ALLOGENEIC DONOR-DERIVED CD19-CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR RELAPSED B-CELL MALIGNANCIES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Muhsen, I. N. [1 ]
Cruz, H. [2 ,3 ]
Zhang, H. [2 ,3 ]
Thakkar, S. G. [2 ,3 ]
Grilley, B. [2 ,3 ]
Gee, A. P. [2 ,3 ]
Heslop, H. [2 ,3 ]
Brenner, M. [2 ,3 ]
Ramos, C. A. [2 ,3 ]
机构：
[1] Houston Methodist, Med, Houston, TX USA
[2] Baylor Coll Med, Ctr Cell & Gene Therapy, Texas Childrens Hosp, Houston, TX USA
[3] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
CYTOTHERAPY | 2022年 / 24卷 / 05期
关键词：
Allogeneic; CAR T cells;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
18
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Allogeneic Donor-Derived CD19-Chimeric Antigen Receptor (CAR) T Cells for Relapsed B-Cell Malignancies After Hematopoietic Stem Cell Transplantation
    Muhsen, Ibrahim N.
    Cruz, Helton
    Zhang, Huimin
    Thakkar, Sachin G.
    Grilley, Bambi
    Gee, Adrian P.
    Heslop, Helen E.
    Brenner, Malcolm K.
    Ramos, Carlos A.
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 227 - 227
  • [2] Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    马润芝
    [J]. China Medical Abstracts (Internal Medicine), 2021, (04) : 228 - 229
  • [3] Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
    Zhang, Cheng
    Gao, Lei
    Liu, Yao
    Gao, Li
    Kong, Pei-Yan
    Liu, Jun
    Huang, Ruihao
    Ma, Ying-Ying
    Zeng, Defu
    Xiong, Qing-Hui
    Mei, Wei-Ling
    Liu, Jia
    Jiang, Peng-Fei
    Ye, Xun
    Han, De-Ping
    Cao, Wei
    Zhang, Xi
    [J]. BLOOD, 2019, 134
  • [4] Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    卓亚琪
    [J]. ChinaMedicalAbstracts(InternalMedicine), 2024, 41 (02) : 123
  • [5] Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation
    Jiang, Ying
    Feng, Dan
    Zhu, Jun
    Wei, Daolin
    Zhao, Chuxian
    Liu, Huixia
    Shao, Shan
    Wang, Chun
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation
    Hua, Jingsheng
    Zhang, Jian
    Wu, Xiaoxia
    Zhou, Lili
    Bao, Xiebing
    Han, Yue
    Miao, Miao
    Li, Caixia
    Fu, Zhengzheng
    Wu, Depei
    Qian, Weiqing
    Qiu, Huiying
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09): : 610 - 616
  • [7] Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
    Jun Liu
    Jiang F. Zhong
    Xi Zhang
    Cheng Zhang
    [J]. Journal of Hematology & Oncology, 10
  • [8] Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
    Liu, Jun
    Zhong, Jiang F.
    Zhang, Xi
    Zhang, Cheng
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 8
  • [9] Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation
    Kochenderfer, James N.
    Dudley, Mark E.
    Carpenter, Robert O.
    Kassim, Sadik H.
    Rose, Jeremy J.
    Telford, William
    Hakim, Frances T.
    Halverson, David
    Fowler, Daniel H.
    Hardy, Nancy M.
    Mato, Anthony
    Hickstein, Dennis D.
    Gea-Banacloche, Juan
    Pavletic, Steven Z.
    Sportes, Claude
    Maric, Irma
    Feldman, Steven
    Hansen, Brenna G.
    Wilder, Jennifer
    Blacklock-Schuver, Bazetta
    Jena, Bipulendu
    Bishop, Michael
    Rosenberg, Steven A.
    Gress, Ronald E.
    [J]. BLOOD, 2013, 122 (21)
  • [10] Allogeneic Hematopoietic Stem Cell Transplantation for Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma after Donor-Derived CD7-Chimeric Antigen Receptor T-Cell Therapy
    Li, Zhihui
    Pen, Xiaojuan
    Wen, Xiaopei
    Li, Jing
    Song, Yanzhi
    Xu, Teng
    Wu, Tong
    [J]. BLOOD, 2021, 138
12345